International Pharmachim Srl, commonly referred to as Pharmachim, is a prominent player in the pharmaceutical industry, headquartered in Italy. Established in 1995, the company has made significant strides in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and intermediates, serving clients across Europe and beyond. With a strong focus on innovation, International Pharmachim Srl offers a diverse range of products that cater to various therapeutic areas, including oncology and cardiology. Their commitment to quality and compliance with international standards has positioned them as a trusted partner in the pharmaceutical supply chain. Notable achievements include certifications from leading regulatory bodies, underscoring their dedication to excellence in the industry.
How does International Pharmachim Srl's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
International Pharmachim Srl's score of 8 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
International Pharmachim Srl, headquartered in Italy, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that International Pharmachim Srl may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it is essential for companies like International Pharmachim Srl to consider developing and communicating their climate strategies to align with global efforts in reducing greenhouse gas emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
International Pharmachim Srl has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
